Table 1.

Baseline characteristics of patients.

	Maintenance < 3 Years (n = 102), 30%		Maintenance ≥ 3 Years (n = 238), 70%		p-Value
Age at Transplant (Yrs, median range)	58	37–73	60	37–75	0.33
Age ≤65	83	81.4	188	79.0	0.62
Age >65	19	18.6	50	21.0
Sex					0.56
Male	57	55.9	141	59.2
Female	45	44.1	97	40.8
Race					0.02
Black	6	5.9	37	15.5
White	96	94.1	197	82.8
Others	0	0.0	4	1.7
Melphalan use					0.91
140	12	11.8	27	11.3
200	90	88.2	211	88.7
Pre-Transplant remission status					0.15
CR/VGPR	55	53.9	153	64.3
PR	38	37.3	64	26.9
SD/PD	9	8.8	21	8.8
Post-Transplant remission status					0.01
CR/VGPR	80	78.4	206	86.6
PR	14	13.7	29	12.2
SD/PD	8	7.8	3	1.3
Cytogenetic risk					0.52
Standard risk	55	63.2	137	67.2
High/Intermediate risk	32	36.8	67	32.8
ISS staging					0.07
1	44	53.7	78	38.6
2	23	28.0	76	37.6
3	15	18.3	48	23.8